tiprankstipranks
Trending News
More News >
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market

Aridis Pharmaceuticals (ARDS) Income Statement

Compare
207 Followers

Aridis Pharmaceuticals Income Statement

Last quarter (Q3 2023), Aridis Pharmaceuticals's total revenue was $417.00K, an increase of Infinity% from the same quarter last year. In Q3, Aridis Pharmaceuticals's net income was $-83.00K. See Aridis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Gross Profit
$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Operating Expenses
$ 29.99M$ 43.71M$ 23.40M$ 30.11M$ 26.87M
Depreciation and Amortization
$ 487.00K$ -722.00K$ 337.00K$ 338.00K$ 283.00K
EBITDA
$ -29.51M$ -44.43M$ -22.06M$ -28.75M$ -23.83M
Operating Income
$ -29.99M$ -43.71M$ -22.40M$ -29.09M$ -24.12M
Other Income/Expenses
$ -378.00K$ 0.00$ 68.00K$ -594.00K$ 2.01M
Pretax Income
$ -30.37M$ -43.19M$ -22.33M$ -29.68M$ -22.11M
Net Income
$ -30.75M$ -42.28M$ -22.33M$ -29.68M$ -22.11M
Per Share Metrics
Basic EPS
$ -1.64$ -3.44$ -2.44$ -3.43$ -7.02
Diluted EPS
$ -1.64$ -3.44$ -2.44$ -3.43$ -7.02
Weighted Average Shares Outstanding
18.78M 12.29M 9.17M 8.46M 3.15M
Weighted Average Shares Outstanding (Diluted)
18.78M 12.29M 9.17M 8.46M 3.15M
Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History